Robinhood Markets Insider Sold Shares Worth $2,547,138, According to a Recent SEC Filing-March 2024-www.financetom.com

Robinhood Markets Insider Sold Shares Worth $2,547,138, According to a Recent SEC Filing

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Robinhood Markets Insider Sold Shares Worth $2,547,138, According to a Recent SEC Filing

May 15, 2024 12:43 AM

03:25 AM EDT, 05/15/2024 (MT Newswires) -- Baiju Bhatt, Director, on May 10, 2024, sold 153,180 shares in Robinhood Markets ( HOOD ) for $2,547,138.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1783879/000178387924000149/xslF345X03/wk-form4_1715726283.xml

Price: 18.04, Change: +0.02, Percent Change: +0.11

Previous page： Sprinklr Names Rory Read CEO Next page： DuPont Q3 Earnings: EPS Beats While Sales Lag, Revises Annual Outlook & More

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Sprinklr Names Rory Read CEO

Nov 5, 2024

10:01 AM EST, 11/05/2024 (MT Newswires) -- Sprinklr ( CXM ) said Tuesday it has appointed Rory Read to serve as its chief executive officer and president. Read, who was also named a member of the board, succeeds co-CEOs Ragy Thomas and Trac Pham. Thomas will act as an advisor to the new CEO and continue as board chair while...

DuPont Q3 Earnings: EPS Beats While Sales Lag, Revises Annual Outlook & More

Nov 5, 2024

DuPont De Nemours, Inc. ( DD ) shares are trading higher after the company reported mixed third-quarter results. The company reported sales growth of 4% year over year to $3.192 billion, missing the consensus of $3.204 billion. Organic sales increased +3% YoY, with a 5% increase in volume offset by a 2% decrease in price. Organic sales by region: EMEA...

Organon Says FDA Extended Review of VTAMA's Supplemental New Drug Application

Nov 5, 2024

10:03 AM EST, 11/05/2024 (MT Newswires) -- Organon (OGN) said Tuesday that the US Food and Drug Administration has extended its review of the company's supplemental new drug application for VTAMA cream to treat atopic dermatitis in children at least two years old and adults. The extended review postpones the target action date to March 12, 2025 from the original...

AGCO Shares Drop As Q3 Results Miss Expectations, 2024 Outlook Cut Amid Softened Global Demand

Nov 5, 2024

AGCO Corp ( AGCO ) shares slipped after the company reported worse-than-expected third-quarter results and lowered its 2024 outlook. AGCO ( AGCO ) reported a third-quarter net sales decline of 24.8% year over year to $2.599 billion, missing the consensus of $2.90 billion. Regional Sales: South America -47% YoY, Europe/Middle East -18.2% YoY, North America -21.8% YoY, and Asia/Pacific/Africa -11.7%...